Acquiring Company
AbbVie Inc.
Acquired Company
Capstan Therapeutics
North ChicagoSan DiegoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaBiotechnologyHealth CareTherapeuticsDescription
AbbVie will acquire Capstan Therapeutics for up to $2.1 billion in cash, bolstering its commitment to advancements in immunology. The acquisition includes Capstan's potential first-in-class in vivo tLNP therapy candidate for autoimmune diseases. The transaction is pending customary closing conditions and regulatory approvals.
Quick answer
AbbVie Inc. is acquiring Capstan Therapeutics for $2.1 billion, announced June 30, 2025. AbbVie Inc. is based in North Chicago, Illinois, United States.
- How much did AbbVie Inc. pay for Capstan Therapeutics?
- The reported deal value is $2.1 billion.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where are AbbVie Inc. and Capstan Therapeutics based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. Capstan Therapeutics is based in San Diego, California, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Cerevel Therapeutics for $45 per share (May 28, 2025)
- AbbVie to acquire Capstan Therapeutics (July 15, 2025)
- AbbVie to acquire Gilgamesh Pharmaceuticals (July 31, 2025)
- Supernus acquires SAGE Therapeutics for USD 8.50/share (July 31, 2025)
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
- BioMarin completes acquisition of Inozyme Pharma (July 1, 2025)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Capstan Therapeutics?
Capstan Therapeutics was acquired by AbbVie Inc., based in North Chicago. The deal was reported on June 30, 2025. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire Capstan Therapeutics?
AbbVie Inc.'s acquisition of Capstan Therapeutics was reported on June 30, 2025. AbbVie will acquire Capstan Therapeutics for up to $2.1 billion in cash, bolstering its commitment to advancements in immunology. The acquisition includes Capstan's potential first-in-class in vivo tLNP therapy candidate for autoimmune diseases. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Capstan Therapeutics do?
Capstan is a biotechnology company with a mission to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA technologies. It is privately held, operating in Biotechnology, and is based in San Diego.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.